Показано 0 из 0
Дата |
---|
20:49 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.854
|
2.055
|
2.01
|
1.98
|
2.08
|
1.98
|
|
|
|
|
1.908
|
2.065
|
2.01
|
1.954
|
2.08
|
1.954
|
|
|
|
|
1.998
|
2.20
|
2.045
|
1.978
|
2.07
|
2.07
|
|
|
|
|
2.00
|
2.16
|
1.936
|
1.918
|
1.94
|
1.938
|
|
|
|
|
1.876
|
2.02
|
1.886
|
1.866
|
1.904
|
1.894
|
|
|
|
|
1.80
|
1.958
|
1.892
|
1.856
|
1.92
|
1.874
|
|
|
|
|
1.804
|
1.954
|
1.91
|
1.862
|
1.91
|
1.866
|
|
|
|
|
1.83
|
1.972
|
1.856
|
1.832
|
1.866
|
1.854
|
|
|
|
|
1.784
|
1.954
|
1.89
|
1.836
|
1.896
|
1.872
|
|
|
|
|
1.812
|
1.972
|
1.986
|
1.878
|
1.996
|
1.878
|
|
|
|
|
Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.